ASP3700

DRUG2 trials

Sponsors

Astellas Pharma Europe B.V.

Conditions

Healthy VolunteersPharmacokinetics of ASP3700

Phase 1

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects

CompletedNCT02155504

Astellas Pharma Europe B.V.Healthy Volunteers, Pharmacokinetics of ASP3700

Start: 2014-05-31End: 2014-10-31Updated: 2014-10-30

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects

WithdrawnNCT02285465

Astellas Pharma Europe B.V.Healthy Volunteers, Pharmacokinetics of ASP3700

Start: 2014-11-30End: 2014-11-30Updated: 2015-01-12